SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 208 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,343,000 | +40.8% | 149,835 | 0.0% | 0.05% | +18.6% |
| Q1 2020 | $954,000 | -23.9% | 149,835 | 0.0% | 0.04% | -8.5% |
| Q4 2019 | $1,254,000 | -3.6% | 149,835 | +24.1% | 0.05% | -11.3% |
| Q2 2019 | $1,301,000 | -43.5% | 120,768 | -50.0% | 0.05% | -43.6% |
| Q1 2019 | $2,304,000 | -16.9% | 241,538 | 0.0% | 0.09% | -21.0% |
| Q4 2018 | $2,773,000 | -4.8% | 241,538 | +40.5% | 0.12% | +12.3% |
| Q3 2018 | $2,914,000 | +70.3% | 171,889 | +42.6% | 0.11% | +63.1% |
| Q2 2018 | $1,711,000 | +105.6% | 120,512 | +60.7% | 0.06% | +116.7% |
| Q2 2015 | $832,000 | -92.2% | 75,000 | -89.0% | 0.03% | -92.9% |
| Q1 2015 | $10,648,000 | +3.1% | 679,100 | 0.0% | 0.42% | -12.6% |
| Q4 2014 | $10,329,000 | +27.7% | 679,100 | -9.5% | 0.48% | +27.4% |
| Q3 2014 | $8,090,000 | +339.9% | 750,100 | +523.0% | 0.38% | +124.3% |
| Q2 2014 | $1,839,000 | +114.6% | 120,400 | +154.0% | 0.17% | +96.5% |
| Q1 2014 | $857,000 | – | 47,400 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |